Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.

Goldenson, Benjamin H; Zhu, Huang; Wang, YunZu Michele; Heragu, Naveen; Bernareggi, Davide; Ruiz-Cisneros, Alessa; Bahena, Andres; Ask, Eivind Heggernes; Hoel, Hanna Julie; Malmberg, Karl-Johan; Kaufman, Dan S

Goldenson, Benjamin H; Zhu, Huang; Wang, YunZu Michele; Heragu, Naveen; Bernareggi, Davide; Ruiz-Cisneros, Alessa; Bahena, Andres; Ask, Eivind Heggernes; Hoel, Hanna Julie; Malmberg, Karl-Johan; Kaufman, Dan S.

Afiliación

Goldenson BH; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Zhu H; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Wang YM; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Heragu N; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Bernareggi D; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Ruiz-Cisneros A; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Bahena A; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Ask EH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Hoel HJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Malmberg KJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Kaufman DS; The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Front Immunol ; 11: 561553, 2020.

Article en En | MEDLINE | ID: mdl-33178188

Asunto(s)

Diferenciación Celular/inmunología; Sangre Fetal/citología; Células Madre Hematopoyéticas/inmunología; Células Madre Pluripotentes Inducidas/citología; Células Asesinas Naturales/inmunología; Neuroblastoma/inmunología; Receptores KIR/inmunología; Diferenciación Celular/genética; Línea Celular Tumoral; Supervivencia Celular/inmunología; Genotipo; Antígenos HLA/genética; Antígenos HLA/inmunología; Antígenos de Histocompatibilidad Clase I/genética; Antígenos de Histocompatibilidad Clase I/inmunología; Humanos; Neuroblastoma/patología; Receptores KIR/genética; Transfección

Palabras clave

KIRs; cancer; natural killer cells; stem cells; umbilical cord blood

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Células Asesinas Naturales / Diferenciación Celular / Receptores KIR / Células Madre Pluripotentes Inducidas / Sangre Fetal / Neuroblastoma Límite: Humans Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google